Cleocin Phosphate

   
Google
 
Web NewDrugInformation.com

Cleocin Phosphate


Drug - Cleocin Phosphate
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Clindamycin Phosphate
Multiple ingredients are in alphabetical order.

Strength - EQ 150MG BASE/ML
The potency of the active ingredient(s), Clindamycin Phosphate. May repeat for multiple part products.

Applicant - PHARMACIA AND UPJOHN
The firm name holding legal responsibility for Cleocin Phosphate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062803
The FDA assigned number to Cleocin Phosphate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Cleocin Phosphate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 16, 1987
The date Cleocin Phosphate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Cleocin Phosphate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Cleocin Phosphate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pharmacia And Upjohn Co
The full name of the firm holding legal responsibility for the new application of Cleocin Phosphate.

Cleocin Phosphate